ANTI-DIABETIC MEDICINES

28th October, 2021 Health

Disclaimer: Copyright infringement not intended.

Context

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) said it has fixed the ceiling prices for 12 anti-diabetic generic medicines, including glimepiride tablets, glucose injection and intermediate acting insulin solution.

Details

To make it possible for every Indian to afford medical treatment, NPPA has fixed the ceiling prices of 12 anti-diabetic generic medicines. These include glimepiride tablet.

NPPA

The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India.
National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution in 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

Functions

To implement and enforce the provisions of the Drugs (Prices Control) Order in accordance with the powers delegated to it.
To deal with all legal matters arising out of the decisions of the Authority.
To monitor the availability of drugs, identify shortages, if any, and to take remedial steps.
To collect/ maintain data on production, exports and imports, market share of individual companies, profitability of companies etc, for bulk drugs and formulations.
To undertake and/ or sponsor relevant studies in respect of pricing of drugs/ pharmaceuticals.
To recruit/ appoint the officers and other staff members of the Authority, as per rules and procedures laid down by the Government.
To render advice to the Central Government on changes/ revisions in the drug policy.[8]
To render assistance to the Central Government in the parliamentary matters relating to the drug pricing.

Daily News Analysis